D.E. Shaw & Co’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $214K | Sell |
64,676
-114,359
| -64% | -$379K | ﹤0.01% | 2818 |
|
2025
Q1 | $519K | Buy |
179,035
+52,571
| +42% | +$152K | ﹤0.01% | 2445 |
|
2024
Q4 | $450K | Buy |
126,464
+95,418
| +307% | +$340K | ﹤0.01% | 2446 |
|
2024
Q3 | $155K | Buy |
31,046
+20,858
| +205% | +$104K | ﹤0.01% | 2853 |
|
2024
Q2 | $26.5K | Sell |
10,188
-85,025
| -89% | -$221K | ﹤0.01% | 2978 |
|
2024
Q1 | $406K | Buy |
+95,213
| New | +$406K | ﹤0.01% | 2491 |
|
2022
Q3 | – | Sell |
-164,607
| Closed | -$106K | – | 3879 |
|
2022
Q2 | $106K | Buy |
164,607
+55,769
| +51% | +$35.9K | ﹤0.01% | 3541 |
|
2022
Q1 | $284K | Buy |
108,838
+21,052
| +24% | +$54.9K | ﹤0.01% | 3469 |
|
2021
Q4 | $341K | Buy |
+87,786
| New | +$341K | ﹤0.01% | 3264 |
|
2020
Q3 | – | Sell |
-283,418
| Closed | -$1.38M | – | 2564 |
|
2020
Q2 | $1.38M | Buy |
283,418
+69,196
| +32% | +$336K | ﹤0.01% | 1781 |
|
2020
Q1 | $469K | Sell |
214,222
-49,195
| -19% | -$108K | ﹤0.01% | 2170 |
|
2019
Q4 | $1.53M | Buy |
+263,417
| New | +$1.53M | ﹤0.01% | 1731 |
|